These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30543413)

  • 21. Multiple Spectroscopic, Docking and Cytotoxic Study of a Synthesized 2,2' Bipyridin Phenyl Isopentylglycin Pt(II) Nitrate Complex: Human Serum Albumin and Breast Cancer Cell Line of MDA-MB231 as Targets.
    Nourizadeh S; Divsalar A; Fekri M; Ghalandari B; Eslami-Moghadam M; Akbar Saboury A; Abbasi S
    J Fluoresc; 2018 Mar; 28(2):551-559. PubMed ID: 29476398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A non-crosslinking platinum-acridine hybrid agent shows enhanced cytotoxicity compared to clinical BCNU and cisplatin in glioblastoma cells.
    Hess SM; Anderson JG; Bierbach U
    Bioorg Med Chem Lett; 2005 Jan; 15(2):443-6. PubMed ID: 15603970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenine-N3 in the DNA minor groove - an emerging target for platinum containing anticancer pharmacophores.
    Guddneppanavar R; Bierbach U
    Anticancer Agents Med Chem; 2007 Jan; 7(1):125-38. PubMed ID: 17266509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the diamine nonleaving group in platinum-acridinylthiourea conjugates on DNA damage and cytotoxicity.
    Guddneppanavar R; Choudhury JR; Kheradi AR; Steen BD; Saluta G; Kucera GL; Day CS; Bierbach U
    J Med Chem; 2007 May; 50(9):2259-63. PubMed ID: 17408248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unprecedented monofunctional metalation of adenine nucleobase in guanine- and thymine-containing dinucleotide sequences by a cytotoxic platinum-acridine hybrid agent.
    Barry CG; Baruah H; Bierbach U
    J Am Chem Soc; 2003 Aug; 125(32):9629-37. PubMed ID: 12904029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Replacement of a thiourea-S with an amidine-NH donor group in a platinum-acridine antitumor compound reduces the metal's reactivity with cysteine sulfur.
    Ma Z; Rao L; Bierbach U
    J Med Chem; 2009 May; 52(10):3424-7. PubMed ID: 19397321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combining aspects of the platinum anticancer drugs picoplatin and BBR3464 to synthesize a new family of sterically hindered dinuclear complexes; their synthesis, binding kinetics and cytotoxicity.
    Brown SD; Trotter KD; Sutcliffe OB; Plumb JA; Waddell B; Briggs NE; Wheate NJ
    Dalton Trans; 2012 Oct; 41(37):11330-9. PubMed ID: 22886151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoparticulate platinum(II) anticancer drug: synthesis and characterization of amphiphilic cyclotriphosphazene-platinum(II) conjugates.
    Yu JY; Jun YJ; Jang SH; Lee HJ; Sohn YS
    J Inorg Biochem; 2007 Nov; 101(11-12):1931-6. PubMed ID: 17709142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
    Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
    J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
    Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
    J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of equatorial and axial carboxylato ligands on the kinetic inertness of platinum(IV) complexes in the presence of ascorbate and cysteine and within DLD-1 cancer cells.
    Chen CK; Zhang JZ; Aitken JB; Hambley TW
    J Med Chem; 2013 Nov; 56(21):8757-64. PubMed ID: 24107138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and cytotoxicity of cis-dichloroplatinum (II) complexes of (1S,3S)-1,2,3,4-tetrahydroisoquinolines.
    Xu G; Yan Z; Wang N; Liu Z
    Eur J Med Chem; 2011 Jan; 46(1):356-63. PubMed ID: 21144623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The synthesis, characterisation and cytotoxicity of bisintercalating (2,2':6',2''-terpyridine)platinum(II) complexes.
    Harper BW; Aldrich-Wright JR
    Dalton Trans; 2015 Jan; 44(1):87-96. PubMed ID: 25407567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of monofunctional platinum(iv) carboxylate precursors for use in Pt(iv)-peptide bioconjugates.
    Smiłowicz D; Metzler-Nolte N
    Dalton Trans; 2018 Nov; 47(43):15465-15476. PubMed ID: 30334055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. pH and thermo dual stimulus-responsive liposome nanoparticles for targeted delivery of platinum-acridine hybrid agent.
    Zhou Q; You C; Ling Y; Wu H; Sun B
    Life Sci; 2019 Jan; 217():41-48. PubMed ID: 30476500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes.
    Sparapani S; Haider SM; Doria F; Gunaratnam M; Neidle S
    J Am Chem Soc; 2010 Sep; 132(35):12263-72. PubMed ID: 20718414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
    Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
    Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin.
    Shi H; Cheng Q; Yuan S; Ding X; Liu Y
    Chemistry; 2015 Nov; 21(46):16547-54. PubMed ID: 26405808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new dinuclear platinum complex with a nitrogen-containing geminal bisphosphonate as potential anticancer compound specifically targeted to bone tissues.
    Margiotta N; Capitelli F; Ostuni R; Natile G
    J Inorg Biochem; 2008 Dec; 102(12):2078-86. PubMed ID: 18760482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of an Anticancer Copper(II) Prodrug Based on the Lys199 Residue of the Active Targeting Human Serum Albumin Nanoparticle Carrier.
    Gou Y; Zhang Y; Zhang Z; Wang J; Zhou Z; Liang H; Yang F
    Mol Pharm; 2017 Jun; 14(6):1861-1873. PubMed ID: 28471669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.